Sample preparation and UHPLC-MS analysis

SL Santosh Lamichhane
LA Linda Ahonen
TD Thomas Sparholt Dyrlund
HS Heli Siljander
HH Heikki Hyöty
JI Jorma Ilonen
JT Jorma Toppari
RV Riitta Veijola
TH Tuulia Hyötyläinen
MK Mikael Knip
MO Matej Orešič
ask Ask a question
Favorite

The solvents and eluent modifiers used in this work were purchased from Sigma-Aldrich (Steinheim, Germany): HPLC-grade chloroform, LC-MS grade acetonitrile (ACN), isopropanol (IPA), water (H2O), methanol (MeOH), ammonium acetate (NH4Ac), analytical grade formic acid (HCOOH) and sodium chloride (NaCl).

The following internal standards were purchased for quality control (QC) and calibration purposes: 1,2-diheptadecanoyl-sn-glycero-3-phosphoethanolamine (PE(17:0/17:0)), N-heptadecanoyl-D-erythro-sphingosylphosphorylcholine (SM(d18:1/17:0)), N-heptadecanoyl-D-erythro-sphingosine (Cer(d18:1/17:0)), 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine (PC(17:0/17:0)), 1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine (LPC(17:0)) and 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (PC(16:0/d31/18:1)) from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA), 1,2-Dimyristoyl-sn-glycero-3-phospho(choline-d13) (PC(14:0/d13)) from Sigma-Aldrich and Tripalmitin-1,1,1-13C3 (TG(16:0/16:0/16:0)-13C3) and Trioctanoin-1,1,1-13C3 (TG(8:0/8:0/8:0)-13C3) from Larodan (Solna, Sweden). Stock solutions (1.0 mg mL−1) of the internal standards were prepared by dissolving the analytes in CHCl3:MeOH (2:1, v/v). The working standard solutions were prepared by further diluting the stock solutions in CHCl3:MeOH (2:1, v/v) to achieve concentrations of 250 ng mL−1 and 3.5 μg mL−1.

Calibration curves using 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine (PC(16:0e/18:1(9Z))), 1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine (PC(18:0p/18:1(9Z))), 1-octadecanoyl-sn-glycero-3-phosphocholine (LPC(18:0)), 1-(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine (PC(18:0p/22:6)) and 1-stearoyl-2-linoleoyl-sn-glycerol (DG(18:0/20:4)) from Avanti Polar Lipids Inc., 1-Palmitoyl-2-Hydroxy-sn-Glycero-3-Phosphatidylcholine (LPC(16:0)) from Larodan, and 1,2,3-Triheptadecanoylglycerol (TG(17:0/17:0/17:0)) and 3β-Hydroxy-5-cholestene 3-linoleate (ChoE(18:2)) from Sigma-Aldrich were prepared to the following concentration levels: 100, 500, 1000, 1500, 2000 and 2500 ng mL−1 (in CHCl3:MeOH, 2:1, v/v) including 250 ng mL−1 of each QC standard.

A total of 428 plasma samples were extracted in randomised order using a modified version of the Folch procedure: 10 μL of 0.9% NaCl, 40 μL of CHCl3:MeOH (2:1, v/v) and 80 μL of the 3.5 μg mL−1 working standards solution were added to 10 μL of each plasma sample. The samples were vortex mixed and incubated on ice for 30 min after which they were centrifuged (9400 × g, 3 min, 4 °C). From the lower layer of each sample, 60 μL was transferred to a glass vial with an insert and 60 μL of CHCl3:MeOH (2:1, v/v) and added to each sample. The samples were re-randomised and stored at −80 °C until analysis on the UHPLC-QTOF-MS system.

The UHPLC system used was a 1290 Infinity system from Agilent Technologies (Santa Clara, California, USA). The system was equipped with a multisampler (maintained at 10 °C) using 10% DCM in MeOH and ACN:MeOH:IPA:H2O (1:1:1:1, v/v/v/v) + 0.1% HCOOH as needle wash solutions after each injection for 7.5 s each, a quaternary solvent manager and a column thermostat (maintained at 50 °C). Separations were performed on an ACQUITY UPLC® BEH C18 column (2.1 mm × 100 mm, particle size 1.7 μm) by Waters (Milford, USA). The flow rate was 0.4 mL min−1 and the injection volume was 1 μL. H2O + 1% NH4Ac (1 M) + 0.1% HCOOH (A) and ACN:IPA (1:1, v/v) + 1% NH4Ac + 0.1% HCOOH (B) were used as the mobile phases for the gradient elution. The gradient was as follows: from 0 to 2 min. 35-80% B, from 2 to 7 min. 80–100% B and from 7 to 14 min 100% B. Each run was followed by a 7 min re-equilibration period under the initial conditions (35% B).

The mass spectrometer coupled to the UHPLC was a 6550 iFunnel QTOF-MS from Agilent Technologies interfaced with a dual jet stream electrospray (dual ESI) ion source. Nitrogen generated by a nitrogen generator (PEAK Scientific, Scotland, UK) was used as the nebulising gas at a pressure of 21 psi, as the drying gas at a flow rate of 14 L min−1 (at 193 °C) and as the sheath gas at a flow rate of 11 L min−1 (at 379 °C). Pure nitrogen (6.0) from Praxair (Fredericia, Denmark) was used as the collision gas. The capillary voltage and the nozzle voltage were kept at 3643 V and 1500 V, respectively. The reference mass solution including ions at m/z 121.0509 and 922.0098 was prepared according to instructions by Agilent and was introduced to the mass spectrometer through the other nebuliser in the dual ESI ion source using a separate Agilent series 1290 isocratic pump at a constant flow rate of 4 mL min−1 (split to 1:100 before the nebuliser). The acquisition mass range was m/z 100–1700 and the instrument was run in extended dynamic range mode with an approximate resolution of 30,000 FWHM measured at m/z 1521.9715 (which is included in the tune mixture) during calibration of the instrument. MassHunter B.06.01 software (Agilent) was used for data acquisition.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A